The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Open accessAbstract
BACKGROUND: Human immunodeficiency virus (HIV) replication and immune activation may increase inflammation and coagulation biomarkers. Limited data exist comparing such biomarkers in persons with and without HIV infection. METHODS: For persons 45-76 years of age, levels of high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, D-dimer, and cystatin C were compared in 494 HIV-infected individuals in the Strategies for Management of Anti-Retroviral Therapy (SMART) study and 5386 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study. For persons 33-44 years of age, hsCRP and IL-6 levels were compared in 287 participants in the SMART study and 3231 participants in the Coronary Artery Development in Young Adults (CARDIA) study. RESULTS: hsCRP and IL-6 levels were 55% (P < . 001) and 62 (P < . 001) higher among HIV-infected participants than among CARDIA study participants. Compared with levels noted in MESA study participants, hsCRP, IL-6, D-dimer, and cystatin C levels were 50%, 152%, 94%, and 27% higher, respectively (P < . 001, for each), among HIV-infected participants. HIV-infected participants receiving antiretroviral therapy who had HIV RNA levels 400 copies/mL had levels higher (by 21% to 60%) (P < . 001) than those in the general population, for all biomarkers. CONCLUSIONS: hsCRP, IL-6, D-dimer, and cystatin C levels are elevated in persons with HIV infection and remain so even after HIV RNA levels are suppressed with antiretroviral therapy. Additional research is needed on the pathophysiology of HIV-induced activation of inflammatory and coagulation pathways, to guide potential interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this therapy does not protect patients from the persistent immune activation, chronic inflammation, and excess risk of developing CVD and frailty131–135.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [132]
In the citing paper
“Many (but not all) biomarkers associated with inflammation (e.g., IL-6, sCD14) and end-organ diseases common in seniors (e.g., cystatin C as a marker of declining renal function) are higher in antiretroviral-treated adults than uninfected adults (50).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citationAssociations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Self-citationCystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman‐Breen, C. O. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,241
Self-citationRelation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Self-citationMacy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797
Self-citation
Cited by
Sorted by citations
Items 401–500 of 870
The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro
Loelius, S. G., Lannan, K. L., Blumberg, N., Phipps, R. P., & Spinelli, S. L. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.07.003 · Cited by 18
Temu, T. M., Zifodya, J. S., Polyak, S. J., Wagoner, J., Wanjalla, C. N., Masyuko, S. J., Nyabiage, J., Kinuthia, J., Bloomfield, G. S., Page, S. T., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002729 · Cited by 18
Melvin, A. J., Warshaw, M. G., Compagnucci, A., Saïdi, Y., Harrison, L., Turkova, A., Tudor‐Williams, G., & and the PENPACT-1 (PENTA 9/PACTG 390/ANRS 103) Study Team (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix050 · Cited by 17
Early cardiac dysfunction in children and young adults with perinatally acquired HIV
McCrary, A. W., Nyandiko, W. M., Ellis, A. M., Chakraborty, H., Muehlbauer, M. J., Koech, M. M., Daud, I. I., Birgen, E., Thielman, N. M., KISSLO, J. A., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002445 · Cited by 17
Phuphuakrat, A., Nimitphong, H., Reutrakul, S., & D, S. S. M. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00284-1 · Cited by 17
Chirouze, C., Journot, V., Moing, V. L., Raffi, F., Piroth, L., Reigadas, S., Cassuto, J., Chêne, G., Leport, C., & Hoen, B. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000416 · Cited by 17
Espíndola, M. S., de Lima, L. J. G., Soares, L. S., Cacemiro, M. D. C., Zambuzi, F. A., Gomes, M. D. S., do Amaral, L. R., Bóllela, V. R., Martins‐Filho, O. A., & Frantz, F. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145261 · Cited by 17
Zhao, M., Luan, X., Cao, G., Liu, W., Xiong, J., Hu, G., Chen, R., Ning, R., Shang, W., Yang, J., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.010 · Cited by 17
Sandkovsky, U., Robertson, K. R., Meza, J. L., High, R., Bonasera, S. J., Fisher, C., Marsh, A. J., Sheehy, M. K., Fox, H. S., & Swindells, S. (2013) · HIV Clinical Trials · doi:10.1310/hct1404-165 · Cited by 17
Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy
Schuster, C., Mayer, F., Wohlfahrt, C., Marculescu, R., Skoll, M., Straßl, R. P., Pávó, N., Popow‐Kraupp, T., Hülsmann, M., Bauer, M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy183 · Cited by 17
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV‐Infected Adults
Sinha, A., Ma, Y., Scherzer, R., Rahalkar, S., Neilan, B. D., Crane, H. M., Drozd, D. R., Martin, J. N., Deeks, S. G., Hunt, P. W., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011037 · Cited by 17
Wang, R. J., Moore, J., Moisi, D. D., Chang, E. G., Byanyima, P., Kaswabuli, S., Musisi, E., Sanyu, I., SESSOLO, A., Lalitha, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216680 · Cited by 17
Kgoadi, K., Bajpai, P., Ibegbu, C., Dkhar, H. K., Enriquez, A. B., Dawa, S., Cribbs, S. K., & Rengarajan, J. (2025) · Nature Communications · doi:10.1038/s41467-025-57668-y · Cited by 18
Feasibility and Preliminary Effects of a Telerehabilitation Program for People Living With HIV
Piraux, E., Reychler, G., Forget, P., Yombi, J. C., & Caty, G. D. (2019) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000005 · Cited by 15
Enkhmaa, B., Anuurad, E., Zhang, W., Li, C., Kaplan, R. C., Lazar, J., Merenstein, D., Karim, R., Aouizerat, B. E., Cohen, M. H., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309137 · Cited by 17
Lai, Y., Chen, Y., Huang, H.-H., Ko, M.-C., Chen, C.-C., & Yen, Y. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818002339 · Cited by 16
Robertson, J., Edén, A., Nyström, K., Hagberg, L., Yilmaz, A., Gostner, J. M., Fuchs, D., Nilsson, S., Blennow, K., Zetterberg, H., et al. (2021) · AIDS · doi:10.1097/qad.0000000000002980 · Cited by 16
Maduna, P. H., Dolan, M., Kondlo, L., Mabuza, H., Dlamini, J. N., Polis, M., Mnisi, T., Orsega, S., Maja, P., Ledwaba, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121843 · Cited by 16
Self-citationHusson, J. S., Stafford, K. A., Bromberg, J. S., Haririan, A., Sparkes, T. M., Davis, C. E. L. B., Redfield, R., & Amoroso, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13985 · Cited by 16
Fractures and the gut microbiome
McGinty, T., & Mallon, P. W. G. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000425 · Cited by 16
Longitudinal evaluation of markers of inflammation in HIV ‐positive and HIV ‐negative Rwandan women
Kiefer, E., Hoover, D. R., Shi, Q., Dusingize, J. C., Sinayobye, J. D., & Anastos, K. (2018) · HIV Medicine · doi:10.1111/hiv.12665 · Cited by 16
Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults
Webel, A. R., Jenkins, T. L., Vest, M., Oliveira, V. H. F., Longenecker, C. T., Liu, J., Currie, J., Sattar, A., & Josephson, R. (2019) · AIDS · doi:10.1097/qad.0000000000002154 · Cited by 16
Saloner, R., Sun-Suslow, N., Morgan, E. E., Lobo, J. D., Cherner, M., Ellis, R. J., Heaton, R. K., Grant, I., Letendre, S. L., & Iudicello, J. E. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100560 · Cited by 15
Shiau, S., Jacobson, D. L., Huo, Y., Kacanek, D., Yee, L. M., Williams, D. B., Haddad, L. B., Serghides, L., Powis, K. M., SPERLING, R. S., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac501 · Cited by 17
Ramana, K. V. (2014) · American journal of public health research · doi:10.12691/ajphr-2-3-1 · Cited by 15
Saracino, A., Monno, L., Scudeller, L., Bruno, G., Ladisa, N., Punzi, G., Volpe, A. R., Lagioia, A., & Angarano, G. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-220 · Cited by 16
Zanetti, H. R., Mendes, E. L., Chagas, A. C. P., Douglas, M. O. G., Lopes, L. T. P., Roever, L., Gonçalves, A., & Resende, E. S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0727-9 · Cited by 15
Patel, P., Sabin, K. M., & Godfrey‐Faussett, P. (2018) · JMIR Public Health and Surveillance · doi:10.2196/10989 · Cited by 15
Prevention of stroke in people living with HIV
Nguyen, I., Kim, A. S., & Chow, F. C. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.01.006 · Cited by 17
Effect of Opioid Use on Immune Activation and HIV Persistence on ART
Azzoni, L., Metzger, D. S., & Montaner, L. J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09959-y · Cited by 15
Crothers, K. A., Petrache, I., Wongtrakool, C., Lee, P. J., Schnapp, L. M., & Gharib, S. A. (2016) · Physiological Reports · doi:10.14814/phy2.12756 · Cited by 15
Baker, J. V., Wolfson, J. A., Peterson, T. E., Mooberry, M. J., Gissel, M., Mystakelis, H. A., Henderson, M. W., Garcia-Myers, K., Rhame, F. S., Schacker, T. W., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa026 · Cited by 15
Self-citationBunet, R., Cardinal, M. R., Ramani, H., Cleret‐Buhot, A., Durand, M., Chartrand‐Lefebvre, C., Routy, J., Thomas, R., Trottier, B., Ancuța, P., et al. (2023) · Viruses · doi:10.3390/v15030700 · Cited by 14
Blaauw, M. J. T., Berrevoets, M. A. H., Vos, W. A. J. W., Groenendijk, A. L., van Eekeren, L. E., Vadaq, N., Weijers, G., van der Ven, A. J. A. M., Rutten, J. H. W., & Riksen, N. P. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030606 · Cited by 14
A Role for TLR Signaling During B Cell Activation in Antiretroviral-Treated HIV Individuals
Siewe, B. T., Keshavarzian, A., French, A. L., Demarais, P., & LANDAY, A. L. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0115 · Cited by 14
Sherman, B. T., Hu, X., Singh, K., Haine, L., Rupert, A. W., Neaton, J. D., Lundgren, J. D., Imamichi, T., Chang, W., & Lane, H. C. (2020) · AIDS · doi:10.1097/qad.0000000000002738 · Cited by 15
Self-citationLi, B., Zhang, L., Liu, Y., Xiao, J., Wang, X., Wei, Y., Fan, L., Duan, Y., Li, G., Kong, Y., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s334046 · Cited by 14
Elevated Risk of Venous Thromboembolism in People Living with HIV
Zhang, Q., Peng, F., Li, M., Yi, Q., Tang, W., & Wu, S. (2022) · Viruses · doi:10.3390/v14030590 · Cited by 15
Detecting Sources of Immune Activation and Viral Rebound in HIV Infection
Wietgrefe, S. W., Duan, L., Anderson, J. L., Marqués, G., Sanders, M. A., Cummins, N. W., Badley, A. D., Dobrowolski, C. N., Karn, J., Pagliuzza, A., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00885-22 · Cited by 14
Martínez-Ayala, P., Alanis-Sánchez, G., Álvarez-Zavala, M., Sánchez-Reyes, K., Ruíz-Herrera, V. V., Cabrera-Silva, R. I., González-Hernández, L. A., Becerra, C. G. R., Cardona-Muñóz, E. G., & Andrade-Villanueva, J. F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282728 · Cited by 14
The severity of COVID-19 across the spectrum of HIV
Miller, K. W., & Gandhi, R. T. (2023) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000791 · Cited by 14
Longenecker, C. T., Kitch, D. W., Sax, P. E., Daar, E. S., Tierney, C., Gupta, S. K., & McComsey, G. A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000557 · Cited by 14
Renal Impairment Is Associated With Coronary Heart Disease in HIV-Positive Men
Campbell, L. J., Desai, M., Hegazi, A., Ibrahim, F., Melikian, N., Hay, P., Fox, J., & Post, F. A. (2012) · HIV Clinical Trials · doi:10.1310/hct1306-343 · Cited by 14
HIV-associated kidney disease in the context of an aging population
Naftalin, C. M., Nathan, B., Hamzah, L., & Post, F. A. (2011) · Sexual Health · doi:10.1071/sh10146 · Cited by 14
Montoya, J. L., Iudicello, J. E., Oppenheim, H. A., Fazeli, P. L., Potter, M., Ma, Q., Mills, P. J., Ellis, R. J., Grant, I., Letendre, S. L., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001404 · Cited by 15
Microbial translocation revisited
Storm-Larsen, C., Stiksrud, B., Eriksen, C., Nowak, P., Holm, K., Thalme, A., Dyrhol‐Riise, A. M., Brix, S., Hov, J. R., & Trøseid, M. (2018) · AIDS · doi:10.1097/qad.0000000000002087 · Cited by 14
Associations between lipids and subclinical coronary atherosclerosis
Whelton, S. P., Deal, J. A., Zikusoka, M. N., Jacobson, L. P., Sarkar, S., Palella, F. J., Kingsley, L., Budoff, M. J., Witt, M. D., Brown, T. T., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002151 · Cited by 14
Does choice of antiretroviral drugs matter for inflammation?
Gutiérrez, M. D. M., Mateo, G. M., Vidal, F., & Domingo, P. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1605902 · Cited by 14
Thudium, R. F., Knudsen, A. D., von Stemann, J. H., Hove‐Skovsgaard, M., Hoel, H., Mocroft, A., Reekie, J., Ronit, A., Gerstoft, J., Vestbo, J., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa600 · Cited by 14
Social Genomics of Methamphetamine Use, HIV Viral Load, and Social Adversity
Li, M. J., Richter, E. I., Okafor, C. N., Kalmin, M. M., Dalvie, S., Takada, S., Gorbach, P. M., SHOPTAW, S. J., & Cole, S. W. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab096 · Cited by 14
Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV
Dirajlal‐Fargo, S., Alam, K., Sattar, A., Kulkarni, M., Funderburg, N., Tang, W. H. W., & McComsey, G. A. (2016) · AIDS · doi:10.1097/qad.0000000000001363 · Cited by 13
Leong, Y. A., Atnerkar, A., & Yu, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00622 · Cited by 14
Gilotra, T. S., & Geraci, S. A. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3154w · Cited by 13
Puhr, R., Petoumenos, K., Huang, R., Templeton, D. J., Woolley, I. J., Bloch, M., Russell, D. B., Law, M. G., & Cooper, D. (2018) · HIV Medicine · doi:10.1111/hiv.12689 · Cited by 15
Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS
Jabs, D. A., Natta, M. L. V., Trang, G., Jones, N. G., Milush, J. M., Cheu, R. K., Klatt, N. R., Pak, J. W., Danis, R. P., & Hunt, P. W. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26070 · Cited by 12
HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers
Proulx, J. M., Ghaly, M., Park, I.-W., & Borgmann, K. (2022) · Biomedicines · doi:10.3390/biomedicines10040768 · Cited by 12
Robbertse, P. S., Doubell, A. F., Steyn, J., Lombard, C. J., Talle, M. A., & Herbst, P. G. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02711-y · Cited by 13
Ripamonti, E., Edén, A., Nilsson, S., Sönnerborg, A. B., Zetterberg, H., & Gisslén, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13594 · Cited by 13
Bailin, S. S., Kropski, J. A., Gangula, R., Hannah, L., Simmons, J. D., Mashayekhi, M., Ye, F., Fan, R., Mallal, S. A., Warren, C. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152003 · Cited by 13
C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals
Westhorpe, C. L. V., Schneider, H. G., Dunne, M. C. M., Middleton, T., Sundararajan, V., Spelman, T. D., Carter, V. M., Crowe, S. M., Dart, A. M., Mijch, A. M., et al. (2014) · Sexual Health · doi:10.1071/sh14130 · Cited by 13
Cedarbaum, E. R., Ma, Y., Scherzer, R., Price, J. C., Adimora, A. A., Bamman, M. M., Cohen, M. H., Fischl, M. A., Matsushita, K., Ofotokun, I., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002319 · Cited by 13
Leng, S. X., Dandorf, S., Li, H., Carlson, J., Hui, J., Mehta, S. H., Piggott, D. A., Islam, S., Manwani, B., & Kirk, G. D. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0134 · Cited by 13
Chau, K. H.-Y., Scherzer, R., Grünfeld, C., Hsue, P. Y., & Shlipak, M. G. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001470 · Cited by 13
Self-citationPatel, D., & Crane, L. R. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0146-8 · Cited by 12
Gene Therapy Targeting HIV Entry
Didigu, C. A., & Doms, R. W. (2014) · Viruses · doi:10.3390/v6031395 · Cited by 14
Association of HIV Infection and Antiretroviral Therapy With Sudden Cardiac Death
Yen, Y., Lai, Y., Chen, Y.-Y., Lai, H.-H., Chuang, P., Chen, C.-C., & Deng, C.-Y. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002161 · Cited by 12
Sarkar, S., Haberlen, S., Whelton, S. P., Schneider, E., Kingsley, L., Palella, F. J., Witt, M. D., Kelesidis, T., Rodríguez, A., Post, W. S., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz474 · Cited by 12
Kousari, A., Moser, C., Olefsky, M., Brown, T. T., Currier, J. S., McComsey, G. A., Scherzinger, A., Stein, J. H., Lake, J. E., & Erlandson, K. M. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002776 · Cited by 14
Lang, R., Humes, E., Hogan, B., Lee, J., D’Agostino, R. B., Massaro, J. M., Kim, A. Y., Meigs, J. B., Borowsky, L. H., He, W. W., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026473 · Cited by 12
Critical Care of Persons Infected with the Human Immunodeficiency Virus
Ganesan, A., & Masur, H. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.01.011 · Cited by 12
Chirch, L. M., Hasham, M., & Kuchel, G. A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000074 · Cited by 13
Gibson, C. M., Jennings, L., Chi, G., Yee, M., Halaby, R. N., Nafee, T., Alkhalfan, F., Kernéis, M., Korjian, S., Daaboul, Y., et al. (2018) · TH Open · doi:10.1055/s-0037-1615288 · Cited by 12
Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV
Fourman, L. T., Czerwonka, N., Shaikh, S. D., Stanley, T. L., Burdo, T. H., Williams, K. C., Fitch, K. V., Lo, J., & Grinspoon, S. K. (2018) · AIDS · doi:10.1097/qad.0000000000001775 · Cited by 12
Siwamogsatham, S., Chutinet, A., Vongsayan, P., Samajarn, J., Putcharoen, O., Aponpong, T., Hiransuthikul, A., Gatechompol, S., Han, W. M., Chattranukulchai, P., et al. (2019) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2019.0126 · Cited by 12
Kamkwalala, A. R., Wang, X., Maki, P. M., Williams, D. W., Valcour, V., Damron, A. L., Tien, P. C., Weber, K. M., Cohen, M. H., Sundermann, E. E., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002283 · Cited by 12
Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation
Eckard, A. R., Hughes, H., Hagood, N. L., O’Riordan, M. A., Labbato, D. E., Kosco, J. C., Scott, S. E., & McComsey, G. A. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002538 · Cited by 12
de Menezes, E. G. M., Deng, X., Liu, J., Bowler, S. A., Shikuma, C. M., Stone, M., Hunt, P. W., Ndhlovu, L. C., & Norris, P. J. (2022) · mBio · doi:10.1128/mbio.03005-21 · Cited by 12
Gupta, M., Miller, C. J., Baker, J. V., Lazar, J., Bogner, J. R., Calmy, A., Soliman, E. Z., & Neaton, J. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.032 · Cited by 12
Self-citationYoung, L. C., Roediger, M. P., Grandits, G., Baker, J. V., Somboonwit, C., Williams, I. G., Lundgren, J. D., Neaton, J. D., & Soliman, E. Z. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.27 · Cited by 12
Self-citationMystakelis, H. A., Wilson, E. M. P., Laidlaw, E., Poole, A. L., Krishnan, S., Rupert, A. W., Welker, J. L., Gorelick, R. J., Lisco, A., Manion, M. M., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003656 · Cited by 11
Self-citationBricaire, F., & Valantin, M. (2011) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32062-x · Cited by 11
Chronic Kidney Disease in the Aging Human Immunodeficiency Virus–Infected Population
Kopp, J. B. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix205 · Cited by 11
He, T., Falwell, E., Brocca‐Cofano, E., & Pandrea, I. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.07.012 · Cited by 12
Kirk, G. D., Dandorf, S., Li, H., Chen, Y., Mehta, S. H., Piggott, D. A., Margolick, J. B., & Leng, S. X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01343 · Cited by 11
Tunggal, H. C., Munson, P. V., O’Connor, M. A., Hajari, N., Dross, S., Bratt, D., Fuller, J. T., Bagley, K., & FULLER, D. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253265 · Cited by 11
Central Nervous System Effects of COVID-19 in People with HIV Infection
Peluso, M. J., Hellmuth, J. M., & Chow, F. C. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00582-x · Cited by 11
Getawa, S., & Adane, T. (2022) · AIDS Research and Treatment · doi:10.1155/2022/6782595 · Cited by 11
Azzoni, L., Giron, L. B., Vadrevu, S. K., Zhao, L., Lalley-Chareczko, L., Hiserodt, E., Fair, M. G., Lynn, K., Trooskin, S. B., Mounzer, K., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4a1221-678rr · Cited by 12
Effect of Abacavir on Acute Changes in Biomarkers Associated with Cardiovascular Dysfunction
Patel, P., Bush, T. J., Overton, T., Baker, J. V., Hammer, J., Kojic, E. M., Conley, L. J., Henry, K., Brooks, J. T., & the SUN Study Investigators (2011) · Antiviral Therapy · doi:10.3851/imp2020 · Cited by 11
Self-citationGloghini, A., Volpi, C. C., Gualeni, A. V., Dolcetti, R., Bongarzone, I., Paoli, P. D., & Carbone, A. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1326815 · Cited by 11
Negredo, E., Jiménez, M., Puig, J., Loste, C., Pérez‐Álvarez, N., Urrea, V., Echeverría, P., Bonjoch, A., Clotet, B., & Blanco, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238575 · Cited by 12
Singh, R., Chakraborty, M., Gautam, A., Roy, S. K., Halder, I., Barber, J., & Garg, A. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104304 · Cited by 10
Vadaq, N., de Wijer, L. V., van Eekeren, L. E., Koenen, H. J. P. M., de Mast, Q., Joosten, L. A. B., Netea, M. G., Matzaraki, V., & van der Ven, A. J. A. M. (2022) · iScience · doi:10.1016/j.isci.2022.105089 · Cited by 11
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Borges, Á. H., Lundgren, J. D., Ridolfo, A., Katlama, C., Antunes, F., Grzeszczuk, A., Blaxhult, A., Мицура, В. М., Doroana, M., Battegay, M., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000433 · Cited by 11
Primary Care of the Human Immunodeficiency Virus Patient
Buckhold, F. R. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.05.010 · Cited by 10
Modelo de seguimiento, organización y gestión de la infección por VIH
Berenguer, J., Álvarez, D., Dodero, J., & Azcoaga-Lorenzo, A. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(18)30247-7 · Cited by 10
Graham, S. M., Nance, R. M., Chen, J., Le, J. M., Chung, D. W., Wurfel, M. M., Tirschwell, D. L., Zunt, J. R., Marra, C. M., Ho, E. L., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab521 · Cited by 10
Kettelhut, A., Bowman, E., Gabriel, J., Hand, B. N., Liyanage, N. P. M., Kulkarni, M., Avila-Soto, F., Lake, J. E., & Funderburg, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879600 · Cited by 10
Jones, R., Enogela, E. M., Buchanan, T., Buford, T. W., Vance, D. E., & Fazeli, P. L. (2023) · Journal of Physical Activity and Health · doi:10.1123/jpah.2022-0304 · Cited by 10
Araújo‐Pereira, M., Krishnan, S., Salgame, P. R., Manabe, Y. C., Hosseinipour, M. C., Bisson, G. P., Sévère, P., Rouzier, V., Leong, S., Mave, V., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102030 · Cited by 10
Metadata
- Authors
- Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., Shlipak, M. G., Tracy, R., & Neaton, J. D.
- Affiliations
- University of Minnesota (US)
- University of Geneva (CH)
- University of Pittsburgh (US)
- UNSW Sydney (AU)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- University of California, San Francisco (US)
- University of Vermont (US)
- Corresponding author
- Neuhaus, Jacqueline
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 201
- Issue
- 12
- Pages
- 1788-1795
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC2872049
- OpenAlex
- W2127517680
- Cited by
- 869
- References
- 33
- Citations by year
- 2026: 29 · 2025: 25 · 2024: 30 · 2023: 50 · 2022: 59 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 53 · 2017: 66 · 2016: 58 · 2015: 65 · 2014: 68 · 2013: 67 · 2012: 69
- FWCI
- 61.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (n01hc95095-66-0-1, n01hc95164-17-0-1, n01hc48050-59-0-1, n01hc48048-58-0-1, n01hc95165-34-0-1, n01hc48047-55-0-1, n01hc95161-24-0-1, n01hc095169-003, n01hc95166-21-0-1, n01hc48049-61-0-1, n01hc95162-31-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, N01-HC- 95159, n01hc95163-22-0-1, n01hc95159-40-0-1, N01‐HC‐95169)
- National Heart, Lung, and Blood Institute (N01HC48050, N01 HC-95159, N01-HC095169, N01-HC-095165, N01 HC 95095, N01 HC095163, N01 HC048048, N01-HC-048049, N01-HC-095159, N01 HC095168, NO1-HC-48049, N01-HC-095162, N01 HC095095, N01-HC-095161, N01 HC048050, N01-HC48048, N01 HC095167, N01-HC-48-049, N01-HC-095160, N01 HC095166, N01 HC095164, N01 HC048047, NO1-HC-95095, N01-HC-480-47, N01 HC95169)
- National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078510)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV infection, inflammatory markers, coagulation markers, renal function, high-sensitivity C-reactive protein, interleukin-6, D-dimer, cystatin C, antiretroviral therapy, viral suppression, immune activation, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Coagulation Disorders, C-Reactive Protein, Female, Fibrin Fibrinogen Degradation Products, Humans, Inflammation, Kidney Diseases, Male, Middle Aged, Biomarkers, HIV Infections, Interleukin-6, Anti-HIV Agents, Viral Load, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review